FDA Documents of Glaxo Smithkline - Rixensart
Glaxo Smithkline - Rixensart is an organization that has been audited by the FDA 11 times between 2000 and 2014 across all 1 sites.
Documents
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | Oct 2014
Available - $199
Issued on: Oct 2, 2014
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2012
Out-of-stock
Issued on: Oct 5, 2012
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2010
Out-of-stock
Issued on: Jun 3, 2010
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2009
Out-of-stock
Issued on: Jun 12, 2009
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2008
Out-of-stock
Issued on: Jun 25, 2008
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2007
Out-of-stock
Issued on: Dec 13, 2007
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2007
Out-of-stock
Issued on: Sep 21, 2007
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2006
Out-of-stock
Issued on: Jun 16, 2006
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2004
Out-of-stock
Issued on: Jun 24, 2004
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2002
Out-of-stock
Issued on: Jun 24, 2002
Biologic Form 483
FDA 483 Glaxo Smithkline - Rixensart, Rixensart | 2000
Out-of-stock
Issued on: Feb 25, 2000
Biologic Form 483
FDA Investigators(18)
- Debra M. Emerson, FDA Investigator
- Omotunde O. Osunsanmi, FDA Investigator
- Cynthia Jim, FDA Investigator
- Paula A. Trost, FDA Investigator
- Christian Lynch, FDA Investigator
- Zhihao Pete Qiu, FDA Investigator
- Sean R. Byrd, FDA Investigator
- Jacqueline M. Diaz Albert, FDA Investigator
- Diaz Albert, Jacqueline M, FDA Investigator
- Pankaj H. Amin, FDA Investigator
- Jonathan McInnis, FDA Investigator
- Gang Wang, FDA Investigator
- Rebecca K. Olin, FDA Investigator
- Rose M. Ashley, FDA Investigator
- Mihaly S. Ligmond, FDA Investigator
- Sid B. Priesmeyer, FDA Investigator
- James C. Maclaughlin, FDA Investigator
- Kirsten L. Vadheim, FDA Investigator